India Pharma Outlook Team | Thursday, 12 May 2022
The Consumer Health division of Bayer announced the launch of the new and improved range of Canesten, thier anti-fungal treatment solution in India. Available in powder and cream formats, the product range offers anti-fungal properties that helps prevent and treat skin infections. An easy-to-use solution, Canesten is a full-cycle skin infection control formulation that not only provides relief from itching but also halts the spread of infection.
Based on Bayer's original research molecule Clotrimazole, the Canesten range brings the required relief as it treats a wide spectrum of fungal skin infections. Canesten anti-fungal dusting powder is used in the prevention, therapy and follow-up treatment of superficial
skin fungal infections and provides 5X relief vs. ordinary talcum powder from prickly heat, redness, skin irritation, itching, and fungal infection. Canesten cream, provides relief from ringworm, jock itch, skin candidiasis, athlete's foot, erythrasma and fungal nail infection, among other fungal skin infections. Canesten S cream is used for treatment of skin fungal infections with inflammatory lesions, while Canesten V6 Tablets proves its effectiveness in the therapy of complicated vulvovaginal candidosis.
Talking about the launch, Sandeep Verma, Country Head, Bayer Consumer Heath India, said, "At Bayer, we are continuously working on our vision of making self-care accessible for all Indians. Women, especially those who lead a more active lifestyle, are prone to fungal skin infections in the hot-humid weather of India. Early symptom detection, diagnosis and treatment can provide relief, reduce the likelihood of recurrence, and improve their quality of life. To address this concern, we've brought our best global solution to India, that’s already trusted by millions of women worldwide.
We want to encourage women to stop being uncomfortable and hiding fungal skin infections, rather treat them with Canesten, and live their lives to the fullest.”
, CDSCO.jpg)
